It is often described as a triple agonist, which means it is designed to stimulate three receptor systems
The primary concerns are cardiovascular strain (increased heart rate/blood pressure) and severe dehydration/malnutrition due to the combined effect of both drugs on your central nervous system and gut.
Many common side effects, like increased urination, thirst, or mild dehydration, often improve within the first few weeks as your body adjusts to the medication
Related Stories Semaglutide fuels rapid growth in US GLP-1RA use as payments rise Semaglutide approval drove a surge in GLP-1 poison center exposures Semaglutide dose may matter more than weight loss for heart health For every patient population, a specified trial was conducted to compare semaglutide with other drugs used to treat T2DM including sodium-glucose cotransporter-2 inhibitors (SGLT2i), insulins, metformin, sulfonylureas (SUs), thiazolidinediones (TZDs), dipeptidyl-peptidase-4 inhibitors (DPP-4i) and other GLP-1Ras